To compare electronically monitored (MEMS) with self-reported adherence in drug users,
including the impact of adherence on HIV load, we conducted a 6-month observational study …

Background The costs, benefits, and cost-effectiveness of screening for human
immunodeficiency virus (HIV) in health care settings during the era of highly active …

Objective: To evaluate the frequency of discontinuation of the first highly active antiretroviral
regimen (HAART) and the factors predictive of discontinuing for toxicity and failure in a …

Background The efficacy of highly active antiretroviral therapy (HAART) in suppression of
HIV-1 is well documented. We investigated virological and clinical outcomes of HAART in …

Introduction: Therapeutic drug monitoring (TDM) may be beneficial when applied to
antiretroviral (ARV). Even though TDM can be a valuable strategy in HIV management, its …

A drastic decrease in incidence has been observed for most human immunodeficiency virus
(HIV)–related opportunistic manifestations after use of highly active antiretroviral therapy …

For people living with HIV, symptoms related to the disease, comorbidities, and treatment
side effects make symptom management essential. Poorly managed symptoms result in …

Background Predictors of virological response to highly active antiretroviral therapy
(HAART) have never been systematically evaluated in a large continental multicenter cohort …

Objective. To determine whether adherence to clinic visits early after initiation of highly
active antiretroviral therapy (HAART) is predictive of long‐term clinical outcome. Design …

Objective To determine the predictors of virological and clinical failure in patients receiving a
protease inhibitor as part of triple therapy. Methods From the French Hospital Database on …